Campone, M.
Bachelot, T.
Penault-Llorca, F.
Pallis, A.
Agrapart, V.
Pierrat, M. J.
Poirot, C.
Dubois, F.
Xuereb, L.
Bossard, C. J.
Guigal-Stephan, N.
Lockhart, B.
Andre, F.
Funding for this research was provided by:
Institut de Recherches Internationales Servier
Article History
Received: 29 November 2018
Accepted: 27 December 2018
First Online: 25 January 2019
Compliance with ethical standards
:
: M. Campone has received consulting fees from Novartis, Lilly, Servier, Abbvie, AstraZeneca and Sanofi. T. Bachelot has received consulting fees and research grants from AstraZeneca, Novartis and Roche and honorarium from Novartis and Roche. F. Penault-Llorca has received consulting fees from Roche, AstraZeneca, MSD, BMS, Novartis, Pfizer, Sanofi and research grants from Roche and AstraZeneca. F. Andre has received research grants from AstraZeneca, Lilly, Novartis and Pfizer and travel/accommodations reimbursements from GlaxoSmithKline, Novartis and Roche. A. Pallis, V. Agrapart, M. J. Pierrat, C. Poirot, F. Dubois and L. Xuereb are employee of Institut de Recherches Internationales Servier. C. J. Bossard, N. Guigal-Stephan and B. Lockhart are employee of Institut de Recherches Servier.